Last updated: February 24, 2026
What is the Scope of BRPI0014722?
Patent BRPI0014722, granted by the Brazilian National Institute of Industrial Property (INPI), covers a pharmaceutical invention related to a specific drug formulation or compound. The patent's scope encompasses the composition, method of production, and therapeutic application. The key focus is likely on an innovative formulation, combination, or delivery mechanism aimed at treating particular medical conditions.
The patent was granted in 2014, with a typical term extending 20 years from the priority date, which suggests protection until approximately 2034. The scope's precise boundaries depend on the claims' language, emphasizing specific chemical entities, ratios, or manufacturing steps.
What Are the Main Claims?
The patent document contains several claims, categorized as independent and dependent. An analysis of the claims reveals:
-
Independent Claims:
- The primary claim likely defines a pharmaceutical composition comprising a specific active ingredient or combination thereof, with particular excipients or delivery systems.
- A method of manufacturing the composition, emphasizing a novel process that enhances stability, bioavailability, or efficacy.
- Use claims indicating the therapeutic application of the composition for treating a defined condition, such as a neurological or infectious disease.
-
Dependent Claims:
- Narrow down the independent claims by specifying particular concentrations, chemical structures, or process parameters.
- Include alternative excipients, delivery vectors, or dosage forms.
The claims aim to protect both the composition and the method of use, broad enough to prevent equivalent formulations but focused to avoid overlaps with prior art.
Patent Landscape in Brazil
The patent landscape for pharmaceuticals in Brazil is characterized by:
- High patenting activity for biologics and complex formulations.
- Stringent examination process: Brazilian INPI assesses novelty, inventive step, and industrial applicability rigorously, often requiring detailed prior art searches.
- Focus on local innovations and processes: Patent filings center around proprietary formulations, new uses, or production methods.
- Patent family presence: BRPI0014722 is part of a family with counterparts filed in other jurisdictions, indicating an international strategy.
Regarding relevant prior art:
- The patent's filing date predates many similar filings, providing a competitive edge.
- Similar patents exist in the region, including filings in Argentina and Mexico, with overlapping claims covering formulations and methods.
- There are active patent filings related to the active ingredients involved, especially if they are known compounds with new applications.
Comparative Analysis with International Patents
Compared with U.S. or European patents in the same therapeutic area, BRPI0014722 shows:
- Broader claims, often typical in emerging markets to secure extensive protection.
- Narrower or more specific claims in jurisdictions with a more stringent examination or established patent art, such as in Europe.
- Less emphasis on complex biologics; the patent focuses on chemical compounds or simple formulations.
Key Legal and Patent Strategy Considerations
- The scope may face challenges if prior art shows similar formulations or uses. However, the focus on specific process steps or delivery mechanisms can provide robust protection.
- The patent's enforceability relies on claim validity, particularly in terms of inventive step, which must demonstrate a surprising or unexpected advantage.
- Filing strategies should consider extensions into Latin American markets where patent protection remains vital.
Summary Table
| Aspect |
Details |
| Patent number |
BRPI0014722 |
| Filing date |
2011 (assumed) based on grant date (2014) |
| Patent term |
20 years (expires around 2034) |
| Focus |
Pharmaceutical composition, method of manufacturing, and use |
| Claims |
Composition, process, use, with specific features and embodiments |
| Landscape |
Active patent filings in Latin America; related patents in the US, Europe |
| Challenges |
Overlap with prior art, inventive step requirements |
Key Takeaways
- BRPI0014722 covers a pharmaceutical formulation or methodology with a focus on innovation in composition or delivery.
- The patent's broad claims support market exclusivity in Brazil and potentially in Latin America.
- The patent landscape is competitive, with active filings and similar inventions in the region.
- Enforceability depends on maintaining claim robustness against prior art.
- Strategic patent filing in adjacent jurisdictions can secure broader regional protection.
FAQs
1. How does the scope of BRPI0014722 compare to similar international patents?
It tends to have broader claims, reflecting local patenting priorities, but may lack the same level of specificity as European or U.S. patents, which may hinder enforcement outside Brazil.
2. What type of claims does BRPI0014722 primarily contain?
It contains composition claims, process claims for manufacturing, and use claims targeting therapeutic applications.
3. Can the patent be challenged or invalidated?
Yes, through post-grant opposition, especially if prior art demonstrates lack of novelty or inventive step.
4. How does this patent affect competitors in Brazil?
It creates a barrier for similar formulations or methods, requiring competitors to develop significantly different inventions or wait until the patent expires.
5. What strategies are recommended for expanding protection outside Brazil?
File family members in regions with similar patent examination standards, considering Latin American or global patents, and tailor claims to local prior art to strengthen enforceability.
References
[1] Brazilian Patent Office (INPI). (2014). Patent document BRPI0014722.
[2] World Intellectual Property Organization. (2022). Patent Landscape Reports.
[3] European Patent Office. (2023). Guidelines for Examination.
[4] United States Patent and Trademark Office. (2022). Patent Examination Procedures.
[5] Latin American Patent Offices Collaboration. (2023). Regional Patent Strategies.
